Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis

Journal:

The Lancet Oncology

Published:

2025-08-07

DOI:

10.1016/s1470-2045(25)00329-8

Affiliations:

5

Authors:

8

Go to article

Institutions	Authors	Share
Peking University (PKU), China	4.500000	0.56
Yale University, United States of America (USA)	1.500000	0.19
London School of Economics and Political Science (LSE), United Kingdom (UK)	1.000000	0.13
Harvard Pilgrim Health Care, United States of America (USA)	1.000000	0.13

Interested in Oncology and Carcinogenesis?